Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124201492 | 12420149 | 2 | F | 201603 | 20160630 | 20160531 | 20160707 | EXP | CH-SM-2016-03874 | CH-UCBSA-2016019434 | UCB | 79.96 | YR | M | Y | 0.00000 | 20160707 | PH | CH | CH |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124201492 | 12420149 | 1 | PS | NEUPRO | ROTIGOTINE | 1 | Transdermal | 3MG/24HR, AS NEEDED (PRN) | Y | U | 21829 | 3 | MG | TRANSDERMAL PATCH | QD | ||||
124201492 | 12420149 | 2 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Oral | 1 G, 2X/DAY (BID) | 6 | G | Y | U | 0 | 1 | G | BID | |||
124201492 | 12420149 | 3 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 250 MG | U | U | 0 | 250 | MG | TABLET | ||||||
124201492 | 12420149 | 4 | C | KETALGIN NOS | KETOROLAC TROMETHAMINE OR METHADONE | 1 | Oral | 5 MG, ONCE DAILY (QD) | U | U | 0 | 5 | MG | TABLET | QD | ||||
124201492 | 12420149 | 5 | C | Propycil | PROPYLTHIOURACIL | 1 | Oral | 50 MG, EV 3 DAYS | U | U | 0 | 50 | MG | ||||||
124201492 | 12420149 | 6 | C | Sifrol | PRAMIPEXOLE | 1 | 0.25 MG, 3X/DAY (TID) | U | U | 0 | .25 | MG | TID | ||||||
124201492 | 12420149 | 7 | C | Finasterax | 2 | UNK | U | 0 | |||||||||||
124201492 | 12420149 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 25 MG, ONCE DAILY (QD) | U | 0 | 25 | MG | QD | |||||||
124201492 | 12420149 | 9 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 50 MG, ONCE DAILY (QD) | U | 0 | 50 | MG | QD | |||||||
124201492 | 12420149 | 10 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124201492 | 12420149 | 1 | Restless legs syndrome |
124201492 | 12420149 | 2 | Antibiotic prophylaxis |
124201492 | 12420149 | 3 | Antibiotic prophylaxis |
124201492 | 12420149 | 4 | Product used for unknown indication |
124201492 | 12420149 | 5 | Product used for unknown indication |
124201492 | 12420149 | 6 | Product used for unknown indication |
124201492 | 12420149 | 7 | Product used for unknown indication |
124201492 | 12420149 | 8 | Rash |
124201492 | 12420149 | 10 | Pruritus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124201492 | 12420149 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124201492 | 12420149 | Application site erythema | |
124201492 | 12420149 | Pemphigoid | |
124201492 | 12420149 | Pruritus | |
124201492 | 12420149 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124201492 | 12420149 | 2 | 20160309 | 20160311 | 0 | |
124201492 | 12420149 | 3 | 20160302 | 201603 | 0 | |
124201492 | 12420149 | 8 | 20160311 | 20160313 | 0 | |
124201492 | 12420149 | 9 | 20160314 | 0 | ||
124201492 | 12420149 | 10 | 20160314 | 0 |